Indefinite Delivery Contract DOC50YABC266045
Award Date 10/1/03
Last Date to Order 9/30/07
Funding Federal Agency
Not listed Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- This Indefinite Delivery Contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to IIT Research Institute (IITRI), a non-profit contract research organization. The contract, with a ceiling value of $0, is part of the Preclinical Agent Development Assays 2012-2016 program and supports preclinical in vitro and in vivo agent development assays. Under this IDC, IITRI provides a range of preclinical research...
- This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a subsidiary of the Illinois Institute of Technology. The contract has a ceiling value of $146.3 million and a period of performance through July 2031. The purpose of this IDC is to provide NIAID with a range of preclinical research services related to the development and...
- This federal Indefinite Delivery Contract (IDC) was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Mriglobal, doing business as Midwest Research Institute, a 501(c)(3) not-for-profit research organization. The $49,990,000 single-award IDC has an ultimate completion date of June 30, 2028 and does not have a set-aside designation. Under this IDC, Mriglobal is providing a range of scientific research, testing, and product...
- This Indefinite Delivery Contract (IDC) was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, to the prime contractor Southern Research Institute, a non-profit research organization located in Birmingham, Alabama. The IDC, with a ceiling value of $17,891,012, is to provide CRO (Contract Research Organization) support for NCATS' Medicinal Chemistry for Lead Optimization program. This includes services...
- This indefinite delivery contract was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health within the Department of Health and Human Services, to IIT Research Institute (IITRI), a non-profit contract research organization. The $74,995,000 multiple-award contract, titled the "PREVENT Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Biomarkers," supports preclinical efficacy and biomarker evaluation, manufacturing, and...
- The Indefinite Delivery Contract (IDC) with ID 75N91024D00006 was awarded by the National Cancer Institute (NCI), a civilian agency, to the Weill Medical College of Cornell University. This multiple-award IDC, with a ceiling value of $149,995,000, supports the PREVENT Cancer Preclinical Drug Development Program through the provision of preclinical research services. The IDC's scope includes evaluating the efficacy of potential cancer preventive agents, identifying relevant biomarkers, developing...
- This Indefinite Delivery Contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract has a total ceiling value of $50,000,000 and a period of performance ending on September 14, 2032. The prime contractor is Research Triangle Institute (RTI International), a non-profit research organization headquartered in North Carolina. The contract is intended to provide NIAID with...
- This indefinite delivery contract (IDC) was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to the Lovelace Biomedical Research Institute. The contract has a ceiling value of $48,882,666.00 and a period of performance through August 5, 2030. The purpose of this IDC is to obtain pharmacology studies, animal model development, and related services to support NCATS' Division of Preclinical Innovation drug...
- This Indefinite Delivery Contract (IDC) was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. federal government, to In Vitro Strategies Limited Liability Company, a woman-owned small business. The contract has a total ceiling value of $187,438.64 and was set aside for small businesses. The purpose of this IDC is to provide in-vitro research and related services to support NIDA's mission. While the full scope of contracted work is not detailed, the...
- The primary Indefinite Delivery Contract (IDC) is a single-award, non-set-aside contract valued at $50,000,000 awarded on March 9, 2016 by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services. The prime contractor is Charles River Laboratories, Inc., headquartered in Wilmington, Massachusetts, with performance conducted at its Wilmington, MA facility. The contract extends through March 13, 2026 and was subject to a modification on...